EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. HOOD
10. QCOM

Go back to EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy
Regeneron (NASDAQ: REGN) Delayed: 810.31 -17.41 (2.1%)
Previous Close $827.72    52 Week High $592.36 
Open $814.36    52 Week Low $325.35 
Day High $821.17    P/E 212.68 
Day Low $799.42    EPS $3.81 
Volume 556,536